Product Information
DOXYCYCLINE HYCLATE 100 MG TAB is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.1180 per EA under NDC 27808023401. Its NADAC has been published 226 times since Jun 8, 2022.
FDA first approved this application on Oct 9, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Cranbury Pharmaceuticals, LLCNDC
27808023401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYCYCLINE HYCLATEApproval Type
Generic (ANDA)
FDA Application
ANDA211343FDA Approved
10/9/2019
TE Code
AB
On Market Since
10/9/2019
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE HYCLATE 100 MG TAB has been published 226 times since Jun 8, 2022, and over the history we have for it it has declined 16.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1180 per EA |
|---|---|
| All-time high | $0.1480 (Apr 10, 2024) |
| All-time low | $0.0950 (Nov 20, 2024) |
| 52-week high | $0.1241 |
| 52-week low | $0.1129 |
| Median price | $0.1263 |
| Average price | $0.1260 |
| Largest weekly change | +40.4% (Aug 21, 2024) |
| Weeks tracked | 226 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cranbury Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DOXYCYCLINE HYCLATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOXYCYCLINE HYCLATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE HYCLATE 100 MG TAB, manufactured by Cranbury Pharmaceuticals, LLC, is $0.1180 per EA (NDC 27808023401), effective Sep 30, 2026.
How has the price of DOXYCYCLINE HYCLATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE HYCLATE 100 MG TAB has declined 16.5%. It has been tracked across 226 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE HYCLATE 100 MG TAB?
Since Jun 8, 2022, the NADAC for DOXYCYCLINE HYCLATE 100 MG TAB has ranged from a low of $0.0950 (Nov 20, 2024) to a high of $0.1480 (Apr 10, 2024), with a median of $0.1263 per EA.
Are there cheaper alternatives to DOXYCYCLINE HYCLATE 100 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXYCYCLINE HYCLATE 100 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXYCYCLINE HYCLATE 100 MG TAB?
DOXYCYCLINE HYCLATE 100 MG TAB (NDC 27808023401) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.